
Synetro Group
Description
Synetro Group is a Chicago-based private investment and strategic advisory firm that strategically focuses on high-growth companies within the SaaS, health-tech, and business services sectors. The firm distinguishes itself by partnering closely with founders and management teams, aiming to accelerate growth and cultivate market-leading businesses. Their approach is rooted in providing both capital and strategic guidance, positioning them as active collaborators rather than just financial backers.
The firm's investment criteria are clearly defined, targeting companies with revenues typically ranging from $2 million to $20 million. Synetro Group seeks businesses that are either already profitable or demonstrate a clear and credible path to achieving profitability, coupled with significant growth potential. This selective approach ensures they align with robust businesses poised for expansion.
Synetro Group employs a flexible investment structure, capable of deploying capital across various instruments, including majority or significant minority equity stakes, debt, and hybrid solutions. This adaptability allows them to tailor financial solutions to the unique needs and capital structures of each portfolio company. Their typical first cheque size for investments ranges from $2 million to $10 million, reflecting their commitment to providing substantial capital for growth initiatives.
Beyond capital, Synetro Group emphasizes its role as a strategic advisor. They leverage their expertise to support portfolio companies in areas such as operational efficiency, market expansion, and strategic planning. This hands-on, partnership-oriented model is designed to maximize value creation and help companies navigate complex growth challenges, ultimately aiming to build sustainable, market-leading enterprises within their specialized sectors.
Investor Profile
Synetro Group has backed more than 38 startups, with 0 new investments in the last 12 months alone. The firm has led 5 rounds, about 13% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series B rounds (top funding stages).
- Majority of deals are located in United States, Israel, United Kingdom.
- Strong thematic focus on Health Care, Software, Biotechnology.
- Typical check size: $2M – $10M.
Stage Focus
- Seed (37%)
- Series A (26%)
- Series B (11%)
- Series C (8%)
- Series Unknown (8%)
- Series D (5%)
- Pre Seed (3%)
- Private Equity (3%)
Country Focus
- United States (87%)
- Israel (5%)
- United Kingdom (5%)
- Estonia (3%)
Industry Focus
- Health Care
- Software
- Biotechnology
- Information Technology
- Artificial Intelligence (Ai)
- Machine Learning
- Wellness
- Life Science
- Health Diagnostics
- Medical
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.